Related Experiment Videos

Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV

Insights

This study evaluated Legionella pneumophila susceptibility to 14 antimicrobial agents. Rifampicin, cefoxitin, chloramphenicol, ticarcillin, and parenteral erythromycin showed the highest effectiveness against these bacteria.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Legionella pneumophila is a significant cause of bacterial pneumonia.
  • Understanding antimicrobial susceptibility is crucial for effective treatment of Legionnaires' disease.
  • Previous reports suggested potential oral erythromycin inadequacy.

Purpose of the Study:

  • To assess the in vitro antimicrobial susceptibility of diverse Legionella pneumophila strains.
  • To compare the efficacy of 14 different antimicrobial agents.
  • To identify potential differences in susceptibility among Legionella serogroups.

Main Methods:

  • Agar dilution method with a Steers replicator was used to determine minimal inhibitory concentrations.
  • Inhibitory indices were calculated using mean peak serum levels of antibiotics.
  • Clinical and environmental isolates from 10 geographic areas, including all 4 serogroups, were tested.

Main Results:

  • Rifampicin, cefoxitin, chloramphenicol, ticarcillin, and parenteral erythromycin demonstrated the highest inhibitory indices.
  • Serogroup II isolates showed increased susceptibility to penicillins.
  • Serogroups III and IV isolates were more susceptible to sulfamethoxazole-trimethoprim.
  • No erythromycin resistance was observed in the tested isolates, despite reports of clinical inadequacy.

Conclusions:

  • Several antimicrobial agents, including rifampicin, cefoxitin, chloramphenicol, ticarcillin, and parenteral erythromycin, are highly effective in vitro against Legionella pneumophila.
  • Specific serogroups exhibit differential susceptibility patterns to certain antibiotics.
  • In vitro testing did not reveal erythromycin resistance, suggesting its potential utility in parenteral forms for Legionnaires' disease.

Related Concept Videos